Contract facts
FederalNo full NAICS 423450 intel page yet. Browse NAICS intelligence
4560741351!INTRAOSSEOUS INFUSION SYSTEM is a federal award for Dla Troop Support held by Cardinal Health 200, LLC. Estimated value $111K ($111K obligated). Current period of performance ends May 18, 2023. Place of performance: WAUKEGAN IL.
Recompete timing
PublicCurrent PoP ended May 18, 2023 (1191 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Incumbent footprint
Public recordCardinal Health 200, LLC — $1.6B obligated across 744,407 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract SPE2DV23F1ZPS?
SPE2DV23F1ZPS (4560741351!intraosseous infusion SYSTEM) is a Dla Troop Support award with a potential value of $111K, currently held by Cardinal Health 200, LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded SPE2DV23F1ZPS?
Dla Troop Support awarded SPE2DV23F1ZPS to Cardinal Health 200, LLC (potential $111K).
Who is the incumbent on SPE2DV23F1ZPS?
Cardinal Health 200, LLC is the incumbent with $1.6B across 744407 related awards in SCOUT’s public footprint. The current period of performance ends May 18, 2023.
When does Cardinal Health 200, LLC’s SPE2DV23F1ZPS come up for recompete?
SCOUT tracks a period-of-performance end of May 18, 2023. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.